Published in Cancer Chemother Pharmacol on January 01, 1998
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg (2013) 2.12
Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci (2011) 1.74
Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World J Gastrointest Oncol (2010) 1.29
A new standard of care for the management of peritoneal surface malignancy. Curr Oncol (2011) 1.20
Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol (2009) 1.13
A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol (2010) 1.08
Peritoneal carcinomatosis of colorectal origin. World J Gastrointest Oncol (2010) 0.92
Chemotherapy-induced late transgenerational effects in mice. PLoS One (2011) 0.91
Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol (2009) 0.88
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. J Transl Med (2006) 0.84
Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol (2010) 0.83
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control. Int J Nanomedicine (2015) 0.77
Pharmacokinetic study of perioperative intravenous Ifosfamide. Int J Surg Oncol (2011) 0.77
Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterol Res Pract (2012) 0.77
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol (2016) 0.76
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis. Medicine (Baltimore) (2017) 0.75
Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis. Transl Gastroenterol Hepatol (2016) 0.75
Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res (2016) 0.75
A critical analysis of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy combo in the clinical management of advanced gastric cancer: an effective multimodality approach with scope for improvement. Transl Gastroenterol Hepatol (2016) 0.75
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy. Indian J Surg Oncol (2016) 0.75
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol (1995) 4.33
T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol (2004) 4.15
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37
Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res (1996) 3.00
Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell (1997) 2.66
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg (1987) 2.54
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A (1977) 2.45
An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42
Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg (2004) 2.33
Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev (1984) 2.15
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14
Appendiceal mucocele. Contraindication to laparoscopic appendectomy. Surg Endosc (1998) 2.10
Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg (2000) 2.08
Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 2.08
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol (2006) 1.96
Reconciliation of international administrative coding systems for comparison of colorectal surgery outcome. Colorectal Dis (2014) 1.91
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem (1994) 1.88
Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem (1996) 1.87
Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery (1982) 1.86
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg (1988) 1.81
Preoperative laparoscopy in diagnosis of acute abdominal pain. Lancet (1975) 1.78
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology (2000) 1.78
Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg (2001) 1.77
Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg (1989) 1.70
Characteristics of cell lines established from human colorectal carcinoma. Cancer Res (1987) 1.69
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography. Radiology (1990) 1.65
Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer (1985) 1.61
Effects of cisapride on QT interval in children. J Pediatr (1998) 1.59
Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol (2010) 1.59
Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery (1993) 1.58
Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol (1997) 1.55
Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry (1989) 1.55
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol (1995) 1.53
Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem (1994) 1.51
Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem (1990) 1.51
Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med (1989) 1.51
Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med (1995) 1.49
Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol (1996) 1.49
Acute enlargement and subsequent rupture of an abdominal aortic aneurysm in a patient receiving chemotherapy for pancreatic carcinoma. J Vasc Surg (2000) 1.48
Repeat hepatic resections for colorectal metastases. Surgery (1990) 1.45
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Serial carcinoembryonic antigen assays. Use in detection of cancer recurrence. JAMA (1974) 1.44
Indirect detection of intraoperative carbon monoxide exposure by mass spectrometry during isoflurane anesthesia. Anesthesiology (1995) 1.44
Maternal recall of infant feeding events is accurate. J Epidemiol Community Health (1992) 1.42
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41
Prosthetic mesh repair of large hernias at the site of colonic stomas. Surg Gynecol Obstet (1980) 1.40
Peritoneal approach to prosthetic mesh repair of paraostomy hernias. Ann Surg (1985) 1.36
A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery (1987) 1.35
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg (1994) 1.35
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery (1985) 1.33
Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol (2006) 1.33
Amino acid sequence of rabbit muscle aldolase and the structure of the active center. Science (1974) 1.32
Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. J Biol Chem (1994) 1.32
Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun (2001) 1.30
Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer (1993) 1.29
Patterns of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol (1976) 1.27
A prospective study of hepatic imaging in the detection of metastatic disease. Ann Surg (1982) 1.26
Mapping of the active site of recombinant human erythropoietin. Blood (1997) 1.25
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol (1992) 1.24
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg (1998) 1.24
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum (2000) 1.23
Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol (2006) 1.21
Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery (1995) 1.21
Primary structure of cholera toxin subunit A1: isolation, partial sequences and alignment of the BrCN fragments. FEBS Lett (1979) 1.20
Cloning and characterization of B delta, a novel regulatory subunit of protein phosphatase 2A. FEBS Lett (1999) 1.20
A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol (2001) 1.19
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs (1996) 1.19
Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol (2006) 1.18
Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg (1999) 1.17
Congenital duplication of the gallbladder associated with an anomalous right hepatic artery. Am J Surg (1985) 1.16
Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer. J Surg Oncol (1991) 1.16
Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol (2000) 1.15
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg (1995) 1.15
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Transfusion (2004) 1.15
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. Am J Physiol Lung Cell Mol Physiol (2000) 1.15
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery (1987) 1.15
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ (2000) 1.14
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer (1991) 1.14
Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem (1996) 1.14
Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg (1986) 1.13